Sign in
WithdrawnPhase 2

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

Key facts

Who runs it
M.D. Anderson Cancer Center
Where
Houston, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 2
Started
26 Jan 2022
Ended
27 Dec 2023
Type of study
Interventional
Treatments tested
  • Computed Tomography
  • Indocyanine Green Solution
  • Therapeutic Bronchoscopy
Record updated
23 October 2024
Why it stopped
0 ACTUAL Enrollment must have Overall Recruitment

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age 18-80 years
  • Medically operable
  • Undergoing pulmonary resection for either stage I non-small cell lung cancer (NSCLC) (undergoing segmentectomy) or metastatic disease to the lung
  • Lesions < 2cm in longest diameter
  • Lesions are located at least 1cm from the pleura

Who cannot take part

  • Iodide allergy
  • Serum creatinine > 2.0
  • Pregnant
  • Central lesions

Where in United States

  • M D Anderson Cancer CenterHouston, United States

About the trial

What the trial wants to find out

This phase II trial studies the use of Ion robotic bronchoscope with a mobile computed tomography (CT) scanner to biopsy tumors and inject a fluorescent dye called indocyanine green to mark the tumor during surgery in patients with stage I non-small cell lung cancer or cancer that has spread to the lung (lung metastases). Sometimes small tumors or those that are not on the surface of the lung can be challenging to remove without making larger incisions. Injecting the dye, may help doctors see the tumor more easily, which may allow for smaller incisions and by being able to see the tumor, doctors may be better able to decide where to make the incisions in order to get all of the tumor out.

The group in the trial

  • Device feasibility (bronchoscopy, CT, indocyanine green)Treatment being tested

    During standard of care surgical resection, patients undergo robotic bronchoscopy and CT. Patients also receive indocyanine green via injection.

    Treatment: Computed Tomography, Indocyanine Green Solution, and Therapeutic Bronchoscopy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Resection of Pulmonary Lesions Aided by Robotic Bronchoscopy With Cone CT and INdocyanin Green (REPLACING) Study
Record updated
23 October 2024